Moderna Phase 1 results show coronavirus vaccine safe, induces immune response

CHICAGO – Moderna Inc’s experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers reported on Tuesday.